Abstract Deadline: May 1Presenting recent advances and emerging areas of lymphoma research
No annual dues required for Associate membership. Apply today.
Application Deadline: May 4A one-year grant of $100,000 for physician-scientists to gain experience in early-stage or late-stage clinical development at an AstraZeneca facility.
Abstract Deadline: May 8Present the latest achievements of multidisciplinary research dealing with drug action and resistance.
Honoring distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer
TLR9 Agonist CMP-001-Pembrolizumab Combination Shows Early Efficacy in Patients With Metastatic Melanoma Resistant to Anti-PD-1
Dual Inhibition of IDO1 and PD-L1 Safe in Patients With Advanced Solid Tumors
Short-acting Calcium Channel Blockers Were Associated With Increased Risk of Pancreatic Cancer in Postmenopausal Women
Latest Advances in Lung Cancer Research
Advances in Malignant Lymphoma
AACR-Johnson & Johnson Lung Cancer Innovation Science Grants
Cancer Dormancy and Residual Disease